Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Adenovirus-mediated transfer of type IV collagen α5 chain cDNA into swine kidney in vivo: deposition of the protein into the glomerular basement membrane

Gene Therapy volume 8, pages 882–890 (2001)Cite this article

Abstract

Gene therapy of Alport syndrome (hereditary nephritis) aims at the transfer of a corrected type IV collagen α chain gene into renal glomerular cells responsible for production of the glomerular basement membrane (GBM). A GBM network composed of type IV collagen molecules is abnormal in Alport syndrome which leads progressively to kidney failure. The most common X-linked form of the disease is caused by mutations in the gene for the α5(IV) chain, the α5 chain of type IV collagen. Full-length human α5(IV) cDNA was expressed in HT1080 cells with an adenovirus vector, and the recombinant α5(IV) chain was shown to assemble into heterotrimers consisting of α3(IV) and α4(IV) chains, utilizing a FLAG epitope in the recombinant α5(IV) chain. The results indicate that correction of the molecular defect in Alport syndrome is possible. Previously, we had developed an organ perfusion method for effective in vivo gene transfer into glomerular cells. In vivo perfusion of pig kidneys with the recombinant adenovirus resulted in expression of the α5(IV) chain in kidney glomeruli as shown by in situ hybridization and its deposition into the GBM was shown by immunohistochemistry. The results strongly suggest future possibilities for gene therapy of Alport syndrome.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Atkin CL, Gregory MC, Border WA . Alport syndrome. In: Schrier WW, Gottschalk CW (eds) Diseases of the Kidney Little Brown: Boston 1988 pp 617–641

    Google Scholar 

  2. Tryggvason K, Heikkilä P . Alport syndrome. In: Jamison L (ed.) Principles of Molecular Medicine Humana Press: Totowa, NJ 1998 665–668

    Chapter  Google Scholar 

  3. Barker D et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome Science 1990 248: 1224–1227

    Article  CAS  Google Scholar 

  4. Hostikka SL et al. Identification of a distinct type IV collagen α chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome Proc Natl Acad Sci USA 1990 87: 1606–1610

    Article  CAS  Google Scholar 

  5. Tryggvason K . Mutations in type IV collagen genes and Alport phenotypes. In: Tryggvason K (ed.) Molecular Pathology and Genetics of Alport Syndrome Karger: Basel 1996 154–171

    Google Scholar 

  6. Mochizuki T et al. Identification of mutations in the α(IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome Nat Genet 1994 8: 77–81

    Article  CAS  Google Scholar 

  7. Lemmink KK et al. Mutations in the type IV collage α3 (COL4A3) gene in autosomal recessive Alport syndrome Hum Mol Genet 1994 3: 1269–1273

    Article  CAS  Google Scholar 

  8. Hudson BG, Reeders ST, Tryggvason K . Type IV collagen: Structure, gene organization, and role in human diseases. Molecular basis of goodpasture and Alport syndromes and diffuse leiomyomatosis J Biol Chem 1993 268: 26033–26036

    CAS  PubMed  Google Scholar 

  9. Kühn K . Basement membrane (type IV) collagen Matrix Biol 1994 14: 439–445

    Article  Google Scholar 

  10. Miner JH, Sanes JR . Collagen IV α3, α4, and α5 chains in rodent basal laminae: sequence, distribution, association with laminins, and developmental switches J Cell Biol 1994 127: 879–891

    Article  CAS  Google Scholar 

  11. Leinonen A et al. Complete primary structure of the human type IV collagen α4(IV) chain; comparison with structure and expression of the other α(IV) chains J Biol Chem 1994 269: 26172–26177

    CAS  PubMed  Google Scholar 

  12. Gunwar S et al. Glomerular basement membrane; identification of a novel disulfide cross-linked network of α3, α4 and α5 chain of type IV collagen and its implication for the pathogenesis of Alport syndrome J Biol Chem 1998 273: 8767–8775

    Article  CAS  Google Scholar 

  13. Nakanishi K et al. Immunohistochemical study of α1–α5 chains of type IV collagen in hereditary nephritis Kidney Int 1994 46: 1413–1412

    Article  CAS  Google Scholar 

  14. Kalluri R et al. Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis J Clin Invest 1997 99: 2470–2478

    Article  CAS  Google Scholar 

  15. Tryggvason K et al. Can Alport syndrome be treated by gene therapy Kidney Int 1997 51: 1493–1499

    Article  CAS  Google Scholar 

  16. Heikkilä P et al. Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system – first steps towards gene therapy of Alport syndrome Gene Therapy 1996 3: 21–27

    PubMed  Google Scholar 

  17. Zhou J, Hertz JM, Leinonen A, Tryggvason K . Complete amino acid sequence of the human α5(IV) collagen chain and identification of a single base mutation in exon 23 converting glysine 521 in the collagenous domain to cystein in an Alport syndrome patient J Biol Chem 1992 267: 12475–12481

    CAS  PubMed  Google Scholar 

  18. Martin P et al. High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing J Am Soc Nephrol 1998 9: 2291–2301

    CAS  PubMed  Google Scholar 

  19. Kozak M . Determinants of translational fidelity and efficiency in vertebrate mRNAs Biochimie 1994 76: 815–821

    Article  CAS  Google Scholar 

  20. Kagawa M et al. Epitope-defined monoclonal antibodies against type IV collagen for diagnosis of Alport's syndrome Nephrol Dial Transplant 1997 12: 1238–1241

    Article  CAS  Google Scholar 

  21. Sado Y et al. Establishment by the rat lymph node method of epitope-defined monoclonal antibodies recognizing the six different α chains of human type IV collagen Histochem Cell Biol 1995 104: 267–275

    Article  CAS  Google Scholar 

  22. Yurchenco P et al. The α chain of laminin-1 is independently secreted and drives secretion of its β- and γ-chain partners Proc Natl Acad Sci USA 1997 94: 10189–10194

    Article  CAS  Google Scholar 

  23. Kortesmaa J et al. Recombinant laminin-8 (α4β1γ1) – production, purification and interactions with integrins J Biol Chem 2000 275: 14853–14859

    Article  CAS  Google Scholar 

  24. Zheng K et al. Canine X chromosome-linked hereditary nephritis: a genetic model for human X-linked hereditary nephritis resulting from a single mutation in the gene encoding the α5(IV) chain of type IV collagen Proc Natl Acad Sci USA 1994 91: 3989–3993

    Article  CAS  Google Scholar 

  25. Lees G et al. Glomerular ultrastructural findings similar to hereditary nephritis in 4 English cocker spaniels J Vet Intern Med 1997 11: 80–85

    Article  CAS  Google Scholar 

  26. Miner JH, Sanes JR . Molecular and functional defects in kidneys of mice lacking collagen α3(IV): implications for Alport syndrome J Cell Biol 1996 135: 1403–1413

    Article  CAS  Google Scholar 

  27. Cosgrove D et al. Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome Genes Dev 1996 10: 2981–2992

    Article  CAS  Google Scholar 

  28. Lu W et al. A new model of Alport's syndrome J Am Soc Nephrol 1997 8: 1818A

    Google Scholar 

Download references

Acknowledgements

We are grateful to Tiina Berg, Margareta Andersson and Dr Ehab Rafael for assistance, and thank Ingvild Halbig for care of the animals. This work was supported in part by grants from the Swedish Medical Research Council, the Novo Nordisk Foundation, Hedlund's Foundation, and by a EU grant No. BIO4-CT96–0537.

Author information

Authors and Affiliations

  1. Division of Matrix Biology, Department of Medical Biochemistry and Biophysics, Stockholm, Sweden

    P Heikkilä, T Morita, Y Chen & K Tryggvason

  2. Department of Transplantation Surgery, Huddinge Hospital, Karolinska Institutet, Stockholm, Sweden

    A Tibell & G Wu

  3. Department of Nephrology, Huddinge Hospital, Karolinska Institutet, Stockholm, Sweden

    E Pettersson

  4. Division of Immunology, Shigei Medical Research Institute, Okayama, Japan

    Y Sado

  5. Department of Molecular Biology and Biochemistry, Okayama University Medical School, Okayama, Japan

    Y Ninomiya

Authors
  1. P Heikkilä
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Tibell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Morita
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Y Sado
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Y Ninomiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E Pettersson
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. K Tryggvason
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heikkilä, P., Tibell, A., Morita, T. et al. Adenovirus-mediated transfer of type IV collagen α5 chain cDNA into swine kidney in vivo: deposition of the protein into the glomerular basement membrane. Gene Ther 8, 882–890 (2001). https://doi.org/10.1038/sj.gt.3301342

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301342

Keywords

This article is cited by

Search

Advanced search

Quick links